Overview

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Status:
Completed

Trial end date:
2017-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the prevention of cardiovascular disease by moderate cholesterol lowering therapy, pitavastatin 1mg/day or aggressive cholesterol lowering therapy, pitavastatin 4mg/day in patients with stable coronary artery disease.

Phase:

N/A

Details

Lead Sponsor:

Juntendo University
Katsumi Miyauchi

Collaborators:

Kumamoto University
Kyoto University
Tohoku University
Tokyo University
Yamaguchi University Hospital

Treatments:

Pitavastatin